| abstract |
A pharmaceutical product having anti-tumor activity. Said product contains a combination of (a) at least one detoxified endotoxin or a synthetic non-toxic or acceptably toxic analogue thereof, and (b) muramyl dipeptide (MDP), or a non-pyrogenic or acceptably pyrogenic analogue or prodrug form thereof, in quantities which, on the one hand, are toxicologically acceptable and, on the other hand, possess an effective anti-tumor activity. |